https://pvwatchdaily.com/fda-launches-aems-why-it-matters-for-pharmacovigilance/2026-03-13T10:36:58+00:00https://pvwatchdaily.com/uk-clinical-trial-rules-change-april-2026-pv-teams/2026-03-13T10:37:07+00:00https://pvwatchdaily.com/paho-calls-for-stronger-pharmacovigilance-after-reports-of-glp-1-misuse/2026-03-13T10:37:15+00:00https://pvwatchdaily.com/fda-warning-letter-novo-nordisk-what-it-signals-for-pv-compliance/2026-03-13T10:47:40+00:00https://pvwatchdaily.com/ema-prac-levamisole-withdrawal-safety-review-reminder/2026-03-13T10:44:03+00:00https://pvwatchdaily.com/what-prac-safety-signals-mean-for-pharmacovigilance-teams/2026-03-13T10:38:25+00:00https://pvwatchdaily.com/fda-recommends-earlier-mri-monitoring-leqembi/2026-03-14T18:30:57+00:00https://pvwatchdaily.com/ema-prac-ixchiq-aseptic-meningitis-risk/2026-03-14T18:33:32+00:00https://pvwatchdaily.com/mhra-warns-about-fake-mounjaro-kwikpen-pens/2026-03-14T18:35:47+00:00https://pvwatchdaily.com/mhra-bayer-recall-impurity-above-acceptable-limit/2026-03-14T18:38:28+00:00https://pvwatchdaily.com/what-fda-aems-signal-page-means-for-pv-teams/2026-03-14T18:41:12+00:00https://pvwatchdaily.com/mhra-strengthens-warnings-gabapentinoids-benzodiazepines-z-drugs/2026-03-14T18:49:05+00:00https://pvwatchdaily.com/patent-expirations-pushing-biopharma-toward-tougher-2026/2026-03-14T18:54:02+00:00https://pvwatchdaily.com/fda-good-ai-practice-principles-what-they-mean-for-pv-teams/2026-03-14T19:05:26+00:00https://pvwatchdaily.com/beyond-faers-how-fda-aems-is-expanding-digital-safety-surveillance/2026-03-14T19:05:09+00:00https://pvwatchdaily.com/uk-trial-safety-reporting-2026-what-inspection-ready-teams-should-get-right/2026-03-14T19:08:39+00:00https://pvwatchdaily.com/why-eudravigilance-training-is-a-compliance-control-not-just-admin/2026-03-14T19:11:06+00:00https://pvwatchdaily.com/why-ai-governance-is-becoming-a-career-advantage-in-pharmacovigilance/2026-03-14T19:14:11+00:00https://pvwatchdaily.com/why-eudravigilance-and-e2br3-skills-still-matter-in-2026/2026-03-14T19:18:15+00:00https://pvwatchdaily.com/how-fda-good-ai-practice-principles-translate-to-real-pv-workflows/2026-03-15T19:57:47+00:00https://pvwatchdaily.com/why-aems-signals-a-more-connected-future-for-digital-pharmacovigilance/2026-03-15T20:03:10+00:00https://pvwatchdaily.com/what-the-new-aems-signal-page-means-for-safety-intelligence-teams/2026-03-15T20:08:49+00:00https://pvwatchdaily.com/why-medwatch-still-matters-in-the-age-of-digital-safety-platforms/2026-03-16T16:10:34+00:00https://pvwatchdaily.com/what-the-amended-cir-520-2012-means-for-some-uk-authorised-products/2026-03-16T16:13:29+00:00https://pvwatchdaily.com/why-eudravigilance-training-is-a-compliance-requirement-in-practice/2026-03-16T16:16:00+00:00https://pvwatchdaily.com/a-missing-pil-warning-a-gpvp-inspection-and-a-bigger-compliance-lesson/2026-03-16T18:16:37+00:00https://pvwatchdaily.com/why-ai-governance-is-becoming-a-differentiator-in-pv-careers/2026-03-16T18:18:50+00:00https://pvwatchdaily.com/why-e2br3-and-evweb-skills-still-open-doors-in-2026/2026-03-16T18:20:31+00:00https://pvwatchdaily.com/why-xevmpd-knowledge-still-matters-for-modern-pv-professionals/2026-03-16T18:22:54+00:00https://pvwatchdaily.com/a-missing-safety-warning-in-a-pil-became-a-bigger-gpvp-lesson/2026-03-16T19:26:07+00:00https://pvwatchdaily.com/industry-alert-rising-scrutiny-over-proxy-interviews-false-representation-and-intermediary-misconduct-in-pharmacovigilance-hiring/2026-03-18T21:00:39+00:00https://pvwatchdaily.com/fda-adds-earlier-mri-monitoring-for-leqembi-patients/2026-03-18T21:22:50+00:00https://pvwatchdaily.com/prac-updates-ixchiq-safety-warnings-after-aseptic-meningitis-review/2026-03-18T21:27:02+00:00https://pvwatchdaily.com/mhra-highlights-very-rare-naion-risk-with-semaglutide/2026-03-18T21:39:47+00:00https://pvwatchdaily.com/what-mhras-february-2026-safety-roundup-signals-for-drug-safety-teams/2026-03-18T21:47:09+00:00https://pvwatchdaily.com/why-mhras-30-day-type-ii-safety-variation-route-matters/2026-03-18T21:50:19+00:00https://pvwatchdaily.com/mhras-national-assessment-procedure-update-why-it-matters-in-2026/2026-03-18T21:53:45+00:00https://pvwatchdaily.com/mhra-highlights-very-rare-naion-risk-with-semaglutide-2/2026-03-22T23:27:34+00:00https://pvwatchdaily.com/what-mhras-february-2026-safety-roundup-signals-for-drug-safety-teams-2/2026-03-22T23:28:26+00:00https://pvwatchdaily.com/why-mhras-30-day-type-ii-safety-variation-route-matters-2/2026-03-22T23:29:24+00:00https://pvwatchdaily.com/mhras-national-assessment-procedure-update-why-it-matters-in-2026-2/2026-03-22T23:30:03+00:00https://pvwatchdaily.com/emas-pms-faqs-show-where-product-data-friction-still-exists/2026-03-22T23:32:13+00:00https://pvwatchdaily.com/ctis-sponsor-training-in-june-2026-signals-the-growing-importance-of-trial-system-skills/2026-03-22T23:33:28+00:00https://pvwatchdaily.com/why-emas-mssg-matters-when-shortages-become-safety-issues/2026-03-22T23:35:04+00:00https://pvwatchdaily.com/prac-reviewed-140-psur-recommendations-in-january-2026-what-that-tells-us/2026-03-22T23:38:28+00:00https://pvwatchdaily.com/fdas-action-on-xylazine-imports-shows-how-safety-oversight-extends-beyond-approved-drugs/2026-03-22T23:40:55+00:00https://pvwatchdaily.com/why-product-management-service-and-spor-literacy-can-strengthen-a-pv-career/2026-03-22T23:43:15+00:00https://pvwatchdaily.com/fda-requires-vitamin-b6-deficiency-warning-for-carbidopa-levodopa/2026-03-22T23:57:20+00:00https://pvwatchdaily.com/fda-requests-removal-of-suicidal-ideation-warning-from-glp1-labels/2026-03-23T00:00:11+00:00https://pvwatchdaily.com/mhra-approves-deuruxolitinib-for-severe-alopecia-areata/2026-03-23T00:07:02+00:00https://pvwatchdaily.com/ema-pushes-esmp-training-as-shortage-reporting-matures/2026-03-23T00:06:07+00:00https://pvwatchdaily.com/cvmp-march-2026-meeting-highlights-keep-veterinary-safety-on-the-radar/2026-03-23T00:13:27+00:00https://pvwatchdaily.com/what-the-glp1-label-change-says-about-how-safety-evidence-can-de-escalate/2026-03-23T00:12:23+00:00https://pvwatchdaily.com/why-real-time-safety-visibility-is-becoming-a-regulatory-strategy/2026-03-23T00:17:41+00:00https://pvwatchdaily.com/week-in-pv-fda-b6-warning-glp1-label-change-and-prac-updates/2026-03-23T00:20:44+00:00https://pvwatchdaily.com/global-watch-weekly-mhra-ema-shortages-and-veterinary-developments/2026-03-23T00:23:28+00:00https://pvwatchdaily.com/what-fdas-2026-biologics-safety-page-signals-about-ongoing-regulator-transparency/2026-03-23T00:26:55+00:00https://pvwatchdaily.com/fda-approves-wegovy-hd-in-54-days-under-priority-voucher-pilot/2026-03-23T01:56:13+00:00https://pvwatchdaily.com/ramipril-recall-after-packaging-error-raises-medication-mix-up-risk/2026-03-23T01:59:15+00:00https://pvwatchdaily.com/why-mhras-weekly-field-safety-notices-still-matter-for-safety-monitoring/2026-03-23T02:06:56+00:00